Clinical Trials Directory

Trials / Completed

CompletedNCT02813239

Dual Triggering in Patients With a High Immature Oocyte Rate

Dual Triggering With Gonadotropin-releasing Hormone Agonist and Standard Dose Human Chorionic Gonadotropin in Patients With a High Immature Oocyte Rate

Status
Completed
Phase
Study type
Observational
Enrollment
81 (actual)
Sponsor
IVI Madrid · Academic / Other
Sex
Female
Age
18 Years – 43 Years
Healthy volunteers
Accepted

Summary

In in vitro fertilization (IVF) cycles, even after adequate triggering, some patients present a high rate of immature oocytes retrieved after controlled ovarian stimulation. In vitro oocyte maturation is still an experimental technique, with poorer results than conventional IVF. For that reason improve in in vivo maturation could have a better impact on reproductive outcome.

Detailed description

Investigators performed an observational study analyzing the difference in the percentage of mature oocytes retrieved in patients with more than 50% immature oocytes in a previous IVF cycle triggered with human chorionic gonadotropin (rhCG) compared to the rate of mature oocytes retrieved in subsequent cycles, triggered with both gonadotropin-releasing hormone agonist (GnRHa) and (hCG). The main outcome measure was the number and percentage of mature oocytes retrieved.

Conditions

Interventions

TypeNameDescription
OTHERhCGOocyte maturation with hCG
OTHERhCG + GnRH agonistOocyte maturation with hCG + GnRH agonist

Timeline

Start date
2014-11-01
Primary completion
2014-11-01
Completion
2015-11-01
First posted
2016-06-24
Last updated
2016-06-24

Source: ClinicalTrials.gov record NCT02813239. Inclusion in this directory is not an endorsement.